Information:
Error:
ID
34169
Description
Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01395056
Link
https://clinicaltrials.gov/show/NCT01395056
Keywords
Versions (1)
- 1/15/19 1/15/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 15, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Neoplasms NCT01395056
Eligibility Breast Neoplasms NCT01395056
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT01395056
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
failure to anthracycline and/or taxol chemotherapy;
boolean
ID.2
Item
metastatic tumor is histologically confirmed by immunohistochemical staining to be er-negative and pr-negative. fish testing for her-2-negative;
boolean
ID.3
Item
metastatic tumor can not be removed through surgery procedure;
boolean
ID.4
Item
an eastern cooperative oncology group (ecog) performance status of 0-2;
boolean
ID.5
Item
normal cardiac, hepatic, renal and bone marrow functions;
boolean
ID.6
Item
life expectancy ≥3 months.
boolean
ID.7
Item
central nervous system metastases;
boolean
ID.8
Item
serious or uncontrolled concurrent medical illness;
boolean
ID.9
Item
history of other malignancies;
boolean
ID.10
Item
having been enrolled in some other clinal trials within a month;
boolean